SPD, ADHD and Autism Calming Strategies

In this blog post, Kelly Dorfman, MS, LND provides ideas for calming strategies for those with SPD, ADHD, autism and other chronic health conditions.

The brain needs a balance between excitatory and calming chemicals to control the body’s activity level. A wide variety of chemical messengers, called neurotransmitters, modulate the brain’s tendencies toward arousal or calming.

Adrenaline (or epinephrine) is an excitatory chemical that helps the body respond to danger by dilating the eyes, speeding up the heart and initiating other functions that prepare the body for fight or flight. If an acute response is not necessary, the body can convert adrenaline to dopamine, another excitatory molecule that improves focus and concentration.

Both dopamine and epinephrine are important under the appropriate circumstances. However, if adrenaline is dominant in a preschooler during circle time, he will be unable to settle down. Similarly, if excessive dopamine is present, the result is obsessive, rather than focusing, behavior.

At bedtime, when the body tries to cycle into sleep, the brain may have trouble breaking down the high levels of excitatory neurotransmitters. Thus, children who take Ritalin and related stimulants can have trouble sleeping or can develop obsessive behaviors such as tics.

Avoid Dietary Excitement Inducers

Understanding the chemistry of excitement versus sedation is important if your child is overactive. In children who exhibit overactivity, regulation between the two states is impaired. Often, the problem is an excessive amount of substances being consumed that increase excitatory messengers. The six most common dietary excitement inducers are:

Aspartame (NutraSweet)

Aspartame is made from two amino acids that are the building blocks for stimulating neurotransmitters.

MSG (monosodium glutamate)

MSG directly agitates because several types of glutamate receptors, all of which arouse, are in the brain. For a detailed explanation of how MSG and NutraSweet affect the nervous system, see Excitotoxins: The Taste that Kills, by Russell Blaylock, MD.

Artificial Colors

Artificial colors can strain liver-detoxification systems, leaving half broken-down substances in the blood that cause irritation in susceptible individuals.

Unidentified Allergens

Allergens can irritate the nervous system, presumably due to their ability to cause inflammation and other chemical reactions. The nervous system and immune system exchange information. When the immune system is under siege, it can send instructions to the nervous system to rev up or shut down. To understand the relationship between hidden allergic reactions and behavior, see Doris Rapp’s Is This Your Child?

Excess Sugar

Children can convert excess sugar immediately into available energy. An adult’s metabolism more often turns that extra energy into fat tissue. Sugar can also aggravate a yeast problem.


Caffeine is used precisely for the purpose of inducing excitement!

Calm with Supplements

Avoiding the known stimulants is the first step in calming. But because the brain depends on a separate set of substances for calling, an over-excited state may indicate a shortage of important nutrients. Thus, the second step is adding substances that encourage serenity. The three most important supplements are:


Magnesium enhances muscle relaxation and inhibits the release of the excitatory neurotransmitter, acetylcholine. Many youngsters are deficient in magnesium, due to picky diets and its decreasing levels in the soil. When magnesium is very deficient, muscle twitching can occur.

Therapeutic doses for children over the age of two range from 100 to 300 mg. Toxicity is almost impossible, because, if more magnesium is taken than the body can absorb, the body excretes it as diarrhea.

Essential Fats

These fats are the basis of brain structure. Research indicates that deficiency in essential fatty acid may cause hyperactivity.

Flaxseed oil contains a 1:1 ratio of omega 3 and 6, the two major families of important fats. For children who cannot swallow pills, the addition of organic flax oil, Udo’s Choice, or Total EFA brands of essential fats can be useful. Supplemental essential fats should be added to foods before serving (not cooked into them) and taste-tested weekly. A sour or bitter after-taste signals rancidity and means the oil should be discarded.


GABA (gamma-amino butyric acid) is the most plentiful calming messenger. Calming neurotransmitters are so important that in the brain there is 200-1,000 times the amount of GABA as the dopamine it controls! GABA also decreases muscle tension, but in large doses, can cause drowsiness.

Generally, 300 to 600 mg are used; 1,000 mg can be used for children over 13. Vitamin B-6 is necessary to utilize GABA and magnesium, which is the reason that it reportedly can help in hyperactivity.

To calm your child’s brain, search for balance before reaching for drugs. Remove excitatory chemicals from the diet and use supplements proven to quiet the most hyperactive.

About Kelly Dorfman MS LND

Kelly Dorfman is one of the world’s foremost experts on using nutrition therapeutically to improve brain function, energy and mood. Kelly’s special talent for integrating information from many sources and finding practical solutions has made her a popular speaker and workshop leader. She lectures extensively and is a member of Platform (formerly the National Speakers Association) and has been featured on numerous television programs including CNN’s American Morning.

Kelly’s award winning book, Cure Your Child With Food: The Hidden Connection Between Nutrition and Childhood Ailments (formerly known as What’s Eating Your Child) was given rave reviews by Publishers Weekly and the Washington Post.

As a go-to expert on nutrition issues, Kelly is frequently interviewed and quoted in the media. She has been featured in articles in The Wall Street Journal, Parade, Bethesda magazine, Living Without magazine, and the Huffington Post.

Kelly holds a master’s degree in nutrition/biology and is a licensed nutrition dietitian. She is a co-founder of Developmental Delay Resources, which has merged with Epidemic Answers. You can find out more about Kelly and her practice at kellydorfman.com

Still Looking for Answers?

Visit the Epidemic Answers Practitioner Directory to find a practitioner near you.

Join us at Healing Together, where you’ll find even more resources plus a community to support you, every step of the way.

Sources & References

Blaylock, R.L., et al. Natural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system. Surg Neurol Int. 2012;3:19.

Boyle, N.B., et al. The Effects of Magnesium Supplementation on Subjective Anxiety and Stress-A Systematic Review. Nutrients. 2017 Apr 26;9(5):429.

Brown, M.S., et al. Increased glutamate concentration in the auditory cortex of persons with autism and first-degreer elatives: A(1)H-MR study. Autism Res. 2013;6(1):1–10.

Choudhury, P.R., et al. Glutamate mediated signaling in the pathophysiology of autism spectrum disorders. Pharmacol Biochem Behav 100(2012)841–849

Cocito, L., et al. GABA and phosphatidylserine in human photosensitivity: a pilot study. Epilepsy Res. 1994 Jan;17(1):49-53.

Coghlan, S., et al. GABA System Dysfunction in Autism and Related Disorders: From Synapse to Symptoms. Neurosci Biobehav Rev. 2012;36(9):2044–2055.

DeHavenon, A., et al. The Secret “Spice”: An Undetectable Toxic Cause of Seizure. Neurohospitalist. 2011 Oct; 1(4): 182–186.

Ding, H., et al. Molecular Pathogenesis of Anti-NMDAR Encephalitis. Biomed Res Int. 2015;2015:643409.

D’Souza, C.E., et al. GAD65 antibody-associated autoimmune epilepsy with unique independent bitemporal-onset ictal asystole. Epileptic Disord. 2018 Jun 1;20(3):204-208.

Eimerl, S., et al. Acute glutamate toxicity and its potentiation by serum albumin are determined by the Ca2+ concentration. Neurosci Lett. 130 (1991) 125–127

Fernell, E. Further studies of GABA and Glutamate imbalances in autism are important challenges for future research. Acta Paediatr. 2019 Feb;108(2):200-201.

Ford, T.C., et al. Psychosocial deficits across autism and schizotypal spectra are interactively modulated by excitatory and inhibitory neurotransmission. Autism. 2019 Jul 24:1362361319866030.

Hacohen, Y., et al. N‐methyl‐d‐aspartate (NMDA) receptor antibodies encephalitis mimicking an autistic regression. Dev Med Child Neurol. 2016 Oct;58(10):1092-4.

Hassel, B., et al. Brain infection with Staphylococcus aureus leads to high extracellular levels of glutamate, aspartate, γ-aminobutyric acid, and zinc. J Neurosci Res. 2014 Dec;92(12):1792-800.

Herbert, M.R, et al. Autism and EMF? Plausibility of a pathophysiological link–Part I. Pathophysiology 20.3 (2013): 191-209.

Herbert, M.R., et al. Autism and EMF? Plausibility of a pathophysiological link Part II. Pathophysiology 20.3 (2013): 211-234.

Huang, Y., et al. Pyridoxine Supplementation Improves the Activity of Recombinant Glutamate Decarboxylase and the Enzymatic Production of Gama-Aminobutyric Acid. PLoS One. 2016 Jul 20;11(7):e0157466.

Humphries, P., et al. Direct and indirect cellular effects of aspartame on the brain. Eur J Clin Nutr. 2008 Apr;62(4):451-62.

Kash, S.F., et al. Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci U S A. 1997;94(25):14060–14065.

Khalifa, D., et al. Serum glutamate was elevated in children aged 3-10 years with autism spectrum disorders when they were compared with controls. Acta Paediatr. 2019 Feb;108(2):295-299.

Luo, P., et al. The role of glutamate receptors in traumatic brain injury: implications for postsynaptic density in pathophysiology. Brain Res Bull. 2011 Jul 15;85(6):313-20.

Manev, H., et al. Delayed increase of Ca2+ influx elicited by glutamate: role in neuronal death. Mol Pharmacol. 1989 Jul;36(1):106-12.

Magalhães, J.Z., et al. Prenatal exposure to fipronil disturbs maternal aggressive behavior in rats. Neurotoxicol Teratol. Nov-Dec 2015;52(Pt A):11-6.

Młyniec, K., et al. Essential elements in depression and anxiety. Part I. Pharmacol Rep. 2014 Aug;66(4):534-44.

Naaijen, J., et al. Fronto-Striatal Glutamate in Autism Spectrum Disorder and Obsessive Compulsive Disorder. Neuropsychopharmacology. 2017 Nov;42(12):2456-2465.

Napolini, V., et al. The mitochondrial aspartate/glutamate carrier AGC1 and calcium homeostasis: Physiological links and abnormalities in autism. Mol Neurobiol. 44 (2011) 83–92.

Ou, D., et al. Cross-reactive rubella virus and glutamic acid decarboxylase (65 and 67) protein determinants recognised by T cells of patients with Type I diabetes mellitus. Diabetologia. 2000 Jun;43(6):750-62.

Pall, M.L., The Autism Epidemic Is Caused by EMFs, Acting via Calcium Channels and Chemicals Acting via NMDA-Rs: Downstream Effects Cause Autism (conference presentation). 2015.

Pall, M.L., Electromagnetic fields act via activation of voltage‐gated calcium channels to produce beneficial or adverse effects. Journal of Cellular and Molecular Medicine 17.8 (2013): 958-965.

Palmieri, L., et al. Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC. Mol Psychiatry. 2010 Jan;15(1):38-52.

Qi, J., et al. Enhanced susceptibility to stress and seizures in GAD65 deficient mice. PLoS One. 2018 Jan 29;13(1):e0191794.

Rojas, D.C. The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment. J Neural Transm (Vienna). 2014;121(8):891–905.

Rout, U.K., et al. Presence of GAD65 autoantibodies in the serum of children with autism or ADHD. Eur Child Adolesc Psychiatry. 2012 Mar;21(3):141-7.

Rowley, N.M., et al. Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control. Neurochem Int. 2012 Sep;61(4):546-58.

Sai, Y., et al. Clinical diagnosis and treatment of pediatric anti-N-methyl-D-aspartate receptor encephalitis: A single center retrospective study. Exp Ther Med. 2018 Aug;16(2):1442-1448.

Sartori, S.B., et al. Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment. Neuropharmacology. 2012 Jan;62(1):304-12.

Schauwecker, P.A. The effects of glycemic control on seizures and seizure-induced excitotoxic cell death. BMC Neurosci. 2012 Aug 6;13:94.

Silvestrin, R.B., et al. Animal model of autism induced by prenatal exposure to valproate: altered glutamate metabolism in the hippocampus. BrainRes. 1495 (2013) 52–60.

Terpstra, M., et al. Changes in human brain glutamate concentration during hypoglycemia: insights into cerebral adaptations in hypoglycemia-associated autonomic failure in type 1 diabetes. J Cereb Blood Flow Metab. 2014;34(5):876–882.

Tzang, R.F., et al. Autism Associated With Anti-NMDAR Encephalitis: Glutamate-Related Therapy. Front Psychiatry. 2019 Jun 21;10:440.

Walls, A.B., et al. GAD65 is essential for synthesis of GABA destined for tonic inhibition regulating epileptiform activity. J Neurochem. 2010 Dec;115(6):1398-408.

Wang, Hsiuying. Anti-NMDA Receptor Encephalitis. Int J Mol Sci. 2017 Jan 18;18(1). pii: E193.

Watkins, J.C., et al. The glutamate story. Br J Pharmacol. 2006 Jan; 147(Suppl 1): S100–S108.

Yang, Y., et al. Role of metabotropic glutamate receptor 7 in autism spectrum disorders: A pilot study. Life Sci. 92 (2013) 149–153.

Zhang, Z., et al. Blood Glutamate Levels in Autism Spectrum Disorder: A Systematic Review and Meta-Analysis. PLoS One. 2016 Jul 8;11(7):e0158688.